GlassScriptPhysician profile
Rona Manneh
NPI 1548432511
$1,367.95
in general payments reported to CMS, 2019-2025
16 companies · $661 in 2025
The $661 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2023: $34.12 · 2024: $503 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,197.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $246.86 | 2024-2025 | Ingrezza |
| Novo Nordisk INC | $239.04 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $181.36 | 2019-2025 | Veozah |
| Lilly USA, LLC | $176.26 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Exact Sciences Corporation | $158.02 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astrazeneca Pharmaceuticals LP | $113.82 | 2019-2025 | Farxiga, Airsupra |
| Amgen INC. | $59.66 | 2024-2025 | Evenity, Prolia, Repatha |
| Glaxosmithkline, LLC. | $44.74 | 2019-2025 | Shingrix, Trelegy Ellipta |
| Pfizer INC. | $34.29 | 2023-2024 | |
| Medtronic, INC. | $18.80 | 2024 | Intellis Adaptivestim |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.50 | 2025 | Jardiance |
| Axsome Therapeutics, INC. | $17.50 | 2025 | Auvelity |
| Allergan, INC. | $16.77 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $15.81 | 2025 | Rexulti |
| Eisai INC. | $14.69 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rona Manneh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.